Brownstein: Scientist will give the skinny on Ozempic during symposium at McGill
Dr. Patricia Brubaker has spent decades researching and speaking on studies relating to the development of the intestinal hormone glucagon-like peptide-1 (GLP-1) for the treatment of patients with Type 2 diabetes and obesity. Read More